« Back to Record
Citation APA

Journé, F., Laurent, G., Chaboteaux, C., Nonclercq, D., Durbecq, V., Larsimont, D., & Body, J.-J. (2008). Farnesol, a mevalonate pathway intermediate, stimulates MCF-7 breast cancer cell growth through farnesoid-X-receptor-mediated estrogen receptor activation. Breast cancer research and treatment, 107(1), 49-61. doi:10.1007/s10549-007-9535-6


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/83352

Journé, F., Laurent, G., Chaboteaux, C., Nonclercq, D., Durbecq, V., Larsimont, D., & Body, J.-J. (2008). Farnesol, a mevalonate pathway intermediate, stimulates MCF-7 breast cancer cell growth through farnesoid-X-receptor-mediated estrogen receptor activation. Breast cancer research and treatment, 107(1), 49-61. doi:10.1007/s10549-007-9535-6